期刊文献+

鸟苷三磷酸酶活化蛋白Git2对乳腺癌转移的影响 被引量:1

Effect of GTPase activating protein Git2 on metastasis in breast cancer
原文传递
导出
摘要 目的 探讨鸟苷三磷酸(GTP)酶活化蛋白Git2与乳腺癌转移的关系。方法 以Git2短发夹RNA慢病毒或Git2 cDNA分别对标记荧光素酶的乳腺癌细胞中Git2基因进行敲降或过表达,在雌性小鼠尾静脉或乳腺脂肪垫注射乳腺癌细胞建立乳腺癌转移模型,分析小鼠肿瘤的转移情况。结果 4T1、4TO7、168FARN和67NR乳腺癌细胞中,Git2 mRNA的相对表达水平分别为0.91±0.03、0.125±0.06、0.131±0.04和0.92±0.04,其中内源性低表达Git2蛋白的168FARN细胞和4TO7细胞过表达Git2后,上皮间充质细胞转化分子标记物E-cadherin表达被抑制,N-cadherin及vimentin的表达升高;而内源性高表达Git2蛋白的67NR细胞和4T1细胞敲降Git2后,E-cadherin的表达升高,N-cadherin和vimentin的表达降低。过表达Git2促进了4TO7细胞在肺中从微小转移发展为肿瘤转移灶;抑制Git2的表达使完全没有转移能力的67NR细胞获得向循环系统中内渗的能力,4T1细胞的转移灶克隆形成能力降低。敲降Git2基因的4T1细胞(4T1-luc-KD细胞)肺转移的光子数为(0.4±0.05)×106,低于对照组4T1-luc细胞[(3.0±0.04)×106],差异有统计学意义(P〈0.05)。结论 Git2参与乳腺癌转移的启动和转移灶的克隆形成。 Objective To investigate the effect of GTPase activating protein Git2 on metastasis in breast cancer. Methods Git2 gene over-expression was induced by Git2 cDNA, and Git2 gene knockdown was induced by Git2 ShRNA lentivirus in four breast cancer cell lines. Six-week old wide type female mice were also used in this study. The cells were tagged with luciferase and injected into wide type female mice by tail vein or 4th mammary fat pad, respectively, to establish a cancer metastasis model. In vivo real time imaging system and immunohistoehemical staining were used to detect the cancer metastasis. Results The relative mRNA expression level of Git2 (normalized by GAPDH) in the 4T1,4TO7, 168FARN and 67NR cells were 0.91 ± 0.03, 0. 125 ± 0.06, 0.131± 0.04 and 0.92±0.04, respectively. The expression of EMT marker E-cadherin was inhibited and N-cadherin and vimentin were enhanced when Git2 was over-expressed in 168FARN cells and 4TO7 cells expressing low level of Git2, whereas the expression of E-cadherin was increased and N-cadherin and vimentin were decreased when Git2 was knocked down in 67NR cells and 4T1 ceils expressing high level of Git2. Furthermore, over-expression of Git2 promoted 4TO7 cells to progress from micro-metastasis to macro-metastasis. The down-regulation of Git2 pushed 67NR ceils to intravasate into blood circulation and suppressed the metastatic ability of 4T1 cells. The number of bloluminescence photos of lung metastatic 4T1-Luc-KD cells was (0.4±0.05) × 10^6, compared with (3.0±0.04) × 10^6 in the control 4T1-Luc cells, showing a significant difference (P〈0.05). Conclusion Our results indicate that Git2 is involved in breast cancer initiation and metastatic colonization.
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2016年第7期492-498,共7页 Chinese Journal of Oncology
基金 浙江省自然科学基金(LYl4H160004)
关键词 GTP酶激活蛋白质类 乳腺肿瘤 肿瘤转移 小鼠 Git2 GTPase-activating proteins Breast neoplasms Neoplasm metastasis Mice Git2
  • 相关文献

参考文献2

二级参考文献10

  • 1Lohrisch C, Piccart M. HER2/neu as a predictive factor in breast cancer. Clin Breast Cancer, 2001,2:129-135.
  • 2Cobleigh MA, Vogel CL, Tripathy D, et al. Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease. J Clin Oncol, 1999,17:2639-2648.
  • 3Lee S, Yang W, Lan KH, et al. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells. Cancer Res, 2002,62:5703-5710.
  • 4Slamon DJ, Jones BL, Shak S, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med, 2001,344:783-792.
  • 5Burstein HJ, Harris LN, Gelman R, et al. Preoperative therapy with trastuzumab and paclitaxel followed by sequential adjuvant doxorubicin/cyclophosphamide for HER2 overexpressing stage II or III breast cancer: a pilot study. J Clin Oncol, 2003,21:46-53.
  • 6Jones BL. Trastuzumab: hopes and realities. The Lancet Oncol,2002,3: 137-144.
  • 7Pienkowski T, Fumoleau P, Eiermann W, et al. Taxotere, cisplatin and herceptin (TCH) in first-line HER2 positive metastatic breast cancer (MBC) patients, a phase Ⅱ pilot study by the breast cancer international research group. Proc Am Soc Clin Oncol, 2001,20: 70b.
  • 8Tan-Chiu E, Piccart M. Moving forward: Herceptin in the adjuvant setting. Oncology, 2002,63 Suppl 1:57-63.
  • 9Jian Xu Samy Lamouille Rik Derynck.TGF-β-induced epithelial to mesenchymal transition[J].Cell Research,2009,19(2):156-172. 被引量:228
  • 10王海兵,陈晓峰,王和勇,张慧君.肿瘤侵袭转移相关microRNAs的研究进展[J].中国肺癌杂志,2010,13(2):144-148. 被引量:3

共引文献18

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部